Search results
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks· 2 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has ...
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 2 days agoThose aren't the kind of dividend stocks that investors will want to own. Instead, income-seekers...
AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
FierceBiotech· 2 days agoAbbVie is wading into the waters of psychedelics, penning a pact with Gilgamesh Pharmaceuticals...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 4 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 6 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoBASEL, Switzerland – 14th May 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, announces ...
As White & Case Celebrates 50 Years in D.C., Firm Focuses on Litigation and Regulatory Strengths |...
Law.com· 6 days agoWhile some large law firms are diversifying their offices in Washington, D.C., to become...
Euronext Paris Growth Leaders With High Insider Stakes May 2024
Simply Wall St. via Yahoo Finance· 3 days agoAmidst a backdrop of fluctuating global markets, France's CAC 40 Index has shown resilience with a...
Piramal Pharma Limited Announces Results for Q4 and FY2024
The Pilot News· 5 days agoPiramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter ...
Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab - Royalty Pharma (NASDAQ:RPRX)
Benzinga· 7 days agoRoyalty Pharma to highlight the strength of its development-stage pipeline on its first quarter of 2024 financial results call today at 8:00 a.m. NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty ...
